WISeKey’s WISeSat.Space Subsidiary Successfully Launches Its 21st Satellite to Low Earth Orbit with SpaceX
GlobeNewswire
Today at 11:36am UTC
Elevar Therapeutics Announces FDA Acceptance for Review of New Drug Application for Lirafugratinib as Second-line Cholangiocarcinoma...
GlobeNewswire
Today at 11:31am UTC
Spring Starts in the Bedroom: PHF Unveils Performance-Driven Breathable Bedding Collection for 2026
PR Newswire
Today at 11:30am UTC
Anavex Life Sciences Provides Comprehensive Regulatory Update
GlobeNewswire
Today at 11:30am UTC
Neurolief Secures Additional $6 Million Investment Following FDA Approval of Proliv™Rx, Expanding Access to Brain Neuromodulation Therapy...
PR Newswire
Today at 11:30am UTC
Bicara Therapeutics Reports Fourth Quarter and Full Year 2025 Financial Results and Provides Business Update
GlobeNewswire
Today at 11:30am UTC
BTQ Technologies to Host Live Webinar on 2025 Financial Results and General Corporate Update
PR Newswire
Today at 11:30am UTC
Medicus Pharma Reports KOL Validation of SkinJect Phase 2 Data of 80% Overall Response Rate
GlobeNewswire
Today at 11:30am UTC
AGNICO EAGLE PROVIDES NOTICE OF RELEASE OF FIRST QUARTER 2026 RESULTS, CONFERENCE CALL AND ANNUAL MEETING
PR Newswire
Today at 11:30am UTC
BullFrog AI Announces Commercial Agreement with Top 5 Global Pharmaceutical Company to Identify and Prioritize Therapeutic Target in Major...
GlobeNewswire
Today at 11:30am UTC
BridgeBio Submits NDA to FDA for BBP-418 for Individuals Living with LGMD2I/R9
GlobeNewswire
Today at 11:30am UTC
Bombardier Announces Extension of Consent Solicitation with Respect to its 7.35% Debentures due 2026
GlobeNewswire
Today at 11:30am UTC
Palvella Therapeutics Announces Scientific Publication in Journal of Vascular Anomalies Highlighting the Infiltrative Growth and Therapeutic...
GlobeNewswire
Today at 11:30am UTC
FDA Approves New High Dose Regimen of SPINRAZA® (nusinersen) for Spinal Muscular Atrophy
GlobeNewswire
Today at 11:30am UTC
BeyondSpring Announces Plinabulin and ADC Combination Poster Presentation at AACR Annual Meeting 2026
GlobeNewswire
Today at 11:30am UTC
SEED Therapeutics Announces Poster Presentation at AACR Annual Meeting 2026
GlobeNewswire
Today at 11:30am UTC
Bitfarms to Participate in Jefferies Fireside Chat
GlobeNewswire
Today at 11:30am UTC
InflaRx Highlights Clinical Activity of Vilobelimab in Pyoderma Gangrenosum in Late-Breaker Oral Presentation at 2026 American Academy of...
GlobeNewswire
Today at 11:30am UTC
Capitalzodiac Unveils "Geo-Matrix" – A Revolutionary Analytical Framework for the Global Strategic Minerals Sector
GlobeNewswire
Today at 11:28am UTC
Alterity Therapeutics Receives Positive FDA Feedback Following Type C Meeting on ATH434 Phase 3 Program
GlobeNewswire
Today at 11:25am UTC